FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]

FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]

The FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3] is a highly specific and reliable tool designed for the detection and analysis of CD274, also known as Programmed Death-Ligand 1 (PD-L1), in human samples. This antibody is conjugated with FITC, a fluorescent dye that allows for easy visualization and quantification of CD274 expression in various experimental settings.

CD274, a cell surface protein, plays a crucial role in regulating immune responses by binding to its receptor, Programmed Death-1 (PD-1), on T cells. This interaction leads to the suppression of T cell activation and proliferation, ultimately inhibiting the immune response. The FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3] specifically recognizes CD274/PD-L1 and enables researchers to investigate its expression levels in different cell types, tissues, and disease states.

This antibody has been extensively validated for its specificity and sensitivity in various applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its high affinity and low background staining ensure accurate and reliable results. With the FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3], researchers can gain valuable insights into the role of CD274/PD-L1 in immune regulation, cancer progression, and therapeutic interventions.